Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Columbia Labs

This article was originally published in The Tan Sheet

Executive Summary

Company moves forward in its attempt to shed its OTC marketing presence by signing an agreement with Lil' Drugstore Products. Under the deal, Lil' Drugstore is purchasing the Replens and Diasorb brands and acquiring the U.S. licensing and trademark rights to Legatrin and Vaporizer in a Bottle for "$4.5 mil. plus existing inventory on closing, a royalty stream in excess of $1 mil. annually," Columbia announces April 20. Lil' Drugstore will have the option to buy full rights to the latter two brands for "several million dollars." Proceeds from the sales will be used to focus on Columbia's Rx offerings. The firm is retaining the OTC Advantage-S spermicide as well as its vaginal pH reducer Miphil
Advertisement
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS091116

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel